Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Adenocarcinoma of colon
ADR ID BADD_A06867
ADR Hierarchy
07      Gastrointestinal disorders
07.21      Malignant and unspecified neoplasms gastrointestinal NEC
07.21.01      Malignant intestinal neoplasms
07.21.01.008      Adenocarcinoma of colon
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.13      Gastrointestinal neoplasms malignant and unspecified
16.13.01      Colorectal neoplasms malignant
16.13.01.010      Adenocarcinoma of colon
Description Not Available
MedDRA Code 10001167
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Adenocarcinoma of colon | Adenocarcinoma of colon recurrent | Adenocarcinoma of colon stage I | Adenocarcinoma of colon stage II | Adenocarcinoma of colon stage III | Adenocarcinoma of colon stage IV | Adenocarcinoma of the colon stage 0 | Mucinous adenocarcinoma of colon | Signet-ring cell adenocarcinoma of colon | Adenocarcinoma of sigmoid colon | Adenocarcinoma of colon metastatic
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00151Apixaban0.000065%
BADD_D00195Azathioprine0.000470%
BADD_D00230Bendamustine0.000112%
BADD_D00271Bicalutamide0.001406%
BADD_D00349Capecitabine0.000168%
BADD_D00479Cladribine0.000306%
BADD_D00511Clozapine0.001834%
BADD_D00563Dabigatran0.000367%
BADD_D00623Dexamethasone0.000145%
BADD_D00680Dimethyl fumarate0.001000%
BADD_D01038Goserelin0.001135%
BADD_D01119Ibrutinib0.000168%
BADD_D01136Imatinib0.000224%
BADD_D01253Lenalidomide0.003617%
BADD_D01567Nilotinib0.000112%
BADD_D01834Prednisone0.000036%
BADD_D01913Ranitidine0.000050%
BADD_D01922Regorafenib0.000728%
BADD_D01954Rivaroxaban0.000190%
BADD_D02029Sitagliptin0.000053%
BADD_D02192Thalidomide0.000241%
BADD_D02236Tofacitinib0.000723%
BADD_D02344Vemurafenib0.000112%
BADD_D02407Upadacitinib0.000241%
BADD_D02464Fingolimod0.000844%
BADD_D02511Siponimod0.000241%
The 1th Page    1    Total 1 Pages